Abstract
Loss of Werner syndrome protein function causes Werner syndrome, characterized by increased genomic instability, elevated cancer susceptibility and premature aging. Although WRN is subject to acetylation, phosphorylation and sumoylation, the impact of these modifications on WRN’s DNA metabolic function remains unclear. Here, we examined in further depth the relationship between WRN acetylation and its role in DNA metabolism, particularly in response to induced DNA damage. Our results demonstrate that endogenous WRN is acetylated somewhat under unperturbed conditions. However, levels of acetylated WRN significantly increase after treatment with certain DNA damaging agents or the replication inhibitor HU. Use of DNA repair-deficient cells or repair pathway inhibitors further increase levels of acetylated WRN, indicating that induced DNA lesions and their persistence are at least partly responsible for increased acetylation. Notably, acetylation of WRN correlates with inhibition of DNA synthesis, suggesting that replication blockage might underlie this effect. Moreover, WRN acetylation modulates its affinity for and activity on certain DNA structures, in a manner that may enhance its relative specificity for physiological substrates. Our results also show that acetylation and deacetylation of endogenous WRN is a dynamic process, with sirtuins and other histone deacetylases contributing to WRN deacetylation. These findings advance our understanding of the dynamics of WRN acetylation under unperturbed conditions and following DNA damage induction, linking this modification not only to DNA damage persistence but also potentially to replication stalling caused by specific DNA lesions. Our results are consistent with proposed metabolic roles for WRN and genomic instability phenotypes associated with WRN deficiency.
References
Blander G, Zalle N, Daniely Y, Taplick J, Gray MD, Oren M (2002) DNA damage-induced translocation of the Werner helicase is regulated by acetylation. J Biol Chem 277:50934–50940
Brosh RM Jr, Orren DK, Nehlin JO, Ravn PH, Kenny MK, Machwe A, Bohr VA (1999) Functional and physical interaction between WRN helicase and human replication protein A. J Biol Chem 274:18341–18350
Brosh RM Jr, Majumdar A, Desai S, Hickson ID, Bohr VA, Seidman MM (2001a) Unwinding of a DNA triple helix by the Werner and Bloom syndrome helicases. J Biol Chem 276:3024–3030
Brosh RM Jr, von Kobbe C, Sommers JA, Karmakar P, Opresko PL, Piotrowski J, Dianova I, Dianov GL, Bohr VA (2001b) Werner syndrome protein interacts with human flap endonuclease 1 and stimulates its cleavage activity. EMBO J 20:5791–5801
Brosh RM Jr, Waheed J, Sommers JA (2002) Biochemical characterization of the DNA substrate specificity of Werner syndrome helicase. J Biol Chem 277:23236–23245
Campisi J (2003) Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 38:5–11
Chandler H, Peters G (2013) Stressing the cell cycle in senescence and aging. Curr Opin Cell Biol 25:765–771
Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L, DePinho RA (2004) Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 36:877–882
Chen L, Oshima J (2002) Werner syndrome. J Biomed Biotechnol 2:46–54
Cheng WH, von Kobbe C, Opresko PL, Fields KM, Ren J, Kufe D, Bohr VA (2003) Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol Cell Biol 23:6385–6395
Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, Hickson ID, West SC (2000) Werner’s syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep 1:80–84
Crabbe L, Jauch A, Naeger CM, Holtgreve-Grez Karlseder J (2007) Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci USA 104:2205–2210
Dolan ME, Pegg AE (1997) O6-benzylguanine and its role in chemotherapy. Clin Cancer Res 3:837–847
Dolan ME, Moschel RC, Pegg AE (1990) Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368–5372
Du X, Shen J, Kugan N, Furth EE, Lombard DB, Cheung C, Pak S, Luo G, Pignolo RJ, DePinho RA, Guarente L, Johnson FB (2004) Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 24:8437–8446
Franchitto A, Pirzio LM, Prosperi E, Sapora O, Bignami M, Pichierri P (2008) Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. J Cell Biol 183:241–252
Fukuchi K, Martin GM, Monnat RJ Jr (1989) Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc Natl Acad Sci USA 86:5893–5897
Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW, Jonas JB (1988) Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet 80:135–139
Goto M (1997) Hierarchical deterioration of body systems in Werner’s syndrome: implications for normal ageing. Mech Ageing Dev 98:239–254
Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA (1997) The Werner syndrome protein is a DNA helicase. Nat Genet 17:100–103
Hawker JR Jr (2003) Chemiluminescence-based BrdU ELISA to measure DNA synthesis. J Immunol Methods 274:77–82
Honma M, Tadokoro S, Sakamoto H, Tanabe H, Sugimoto M, Furuichi Y, Satoh T, Sofuni T, Goto M, Hayashi M (2002) Chromosomal instability in B-lymphoblasotoid cell lines from Werner and Bloom syndrome patients. Mutat Res 520:15–24
Horton JK, Stefanick DF, Naron JM, Kedar PS, Wilson SH (2005) Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure. J Biol Chem 280:15773–15785
Huang S, Li B, Gray MD, Oshima J, Mian IS, Campisi J (1998) The premature ageing syndrome protein, WRN, is a 3′→ 5′ exonuclease. Nat Genet 20:114–116
Johnson RE, Yu SL, Prakash S, Prakash L (2007) A role for yeast and human translesion synthesis DNA polymerases in promoting replication through 3-methyladenine. Mol Cell Biol 27:7198–7205
Jung Y, Lippard SJ (2007) Direct cellular responses to platinum-induced DNA damage. Chem Rev 107:1387–1407
Kahyo T, Mostoslavsky R, Goto M, Setou M (2008) Sirtuin-mediated deacetylation pathway stabilizes Werner syndrome protein. FEBS Lett 582:2479–2483
Kaina B, Christmann M, Naumann S, Roos WP (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6:1079–1099
Kamath-Loeb AS, Johansson E, Burgers PM, Loeb LA (2000) Functional interaction between the Werner syndrome protein and DNA polymerase delta. Proc Natl Acad Sci USA 97:4603–4608
Karmakar P, Bohr VA (2005) Cellular dynamics and modulation of WRN protein is DNA damage specific. Mech Ageing Dev 126:1146–1158
Karmakar P, Piotrowski J, Brosh RM Jr, Sommers JA, Miller SP, Cheng WH, Snowden CM, Ramsden DA, Bohr VA (2002) Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation. J Biol Chem 277:18291–18302
Kusumoto R, Muftuoglu M, Bohr VA (2007) The role of WRN in DNA repair is affected by post-translational modifications. Mech Ageing Dev 128:50–57
Laine JP, Opresko PL, Indig FE, Harrigan JA, von Kobbe C, Bohr VA (2003) Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res 63:7136–7146
Lebel M, Spillare EA, Harris CC, Leder P (1999) The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J Biol Chem 274:37795–37799
Li K, Casta A, Wang R, Lozada E, Fan W, Kane S, Ge Q, Gu W, Orren D, Luo J (2008) Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J Biol Chem 283:7590–7598
Li K, Wang R, Lozada E, Fan W, Orren DK, Luo J (2010) Acetylation of WRN protein regulates its stability by inhibiting ubiquitination. PLoS One 5:e10341
Liu JS, Kuo SR, Melendy T (2003) Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents. Mutat Res 532:215–226
Lord CJ, Ashworth A (2008) Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8:363–369
Löser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ (2010) Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Mol Cancer Ther 9:1775–1787
Machwe A, Xiao L, Theodore S, Orren DK (2002) DNase I footprinting and enhanced exonuclease function of the bipartite Werner syndrome protein (WRN) bound to partially melted duplex DNA. J Biol Chem 277:4492–4504
Machwe A, Xiao L, Groden J, Matson SW, Orren DK (2005) RecQ family members combine strand pairing and unwinding activities to catalyze strand exchange. J Biol Chem 280:23397–23407
Machwe A, Xiao L, Groden J, Orren DK (2006) The Werner and Bloom syndrome proteins catalyze regression of a model replication fork. Biochemistry 45:13939–13946
Machwe A, Xiao L, Lloyd RG, Bolt E, Orren DK (2007) Replication fork regression is catalyzed by the combined helicase, strand pairing, and exonuclease activities of the Werner syndrome protein (WRN). Nucleic Acids Res 35:5729–5747
Machwe A, Lozada EM, Li GM, Wold MS, Orren DK (2011) Molecular cooperation between the Werner syndrome protein (WRN) and replication protein A (RPA) in relation to replication fork blockage. J Biol Chem 286:3497–3508
Martin GM, Oshima J (2000) Lessons from human progeroid syndromes. Nature 408:263–266
Mian IS (1997) Comparative sequence analysis of ribonucleases HII, III, II PH and D. Nucleic Acids Res 25:3187–3195
Mohaghegh P, Karow JK, Brosh RM Jr, Jr Bohr VA, Hickson ID (2001) The Bloom’s and Werner’s syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res 29:2843–2849
Moradei O, Maroun CR, Paquin I, Vaisburg A (2005) Histone deacetylase inhibitors: latest developments, trends and prospects. Curr Med Chem Anticancer Agents 5:529–560
Muftuoglu M, Kusumoto R, Speina E, Beck G, Cheng WH, Bohr VA (2008) Acetylation regulates WRN catalytic activities and affects base excision DNA repair. PLoS One 3:e1918
Murakami J, Lee YJ, Kokeguchi S, Tsujigiwa H, Asaumi J, Nagatsuka H, Fukui K, Kuroda M, Tanaka N, Matsubara N (2007) Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines. Oncol Rep 17:1461–1467
Ogburn CE, Oshima J, Poot M, Chen R, Hunt KE, Gollahon KA, Rabinovitch PS, Martin GM (1997) An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet 101:121–125
Orren DK (2006) Werner syndrome: molecular insights into the relationships between defective DNA metabolism, genomic instability, cancer and aging. Front Biosci 11:2657–2671
Orren DK, Brosh RM Jr, Nehlin JO, Machwe A, Gray MD, Bohr VA (1999) Enzymatic and DNA binding properties of purified WRN protein: high affinity binding to single-stranded DNA but not to DNA damage induced by 4NQO. Nucleic Acids Res 27:3557–3566
Orren DK, Theodore S, Machwe A (2002) The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro. Biochemistry 41:13483–13488
Otterlei M, Bruheim P, Ahn B, Bussen W, Karmakar P, Baynton K, Bohr VA (2006) Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest. J Cell Sci 119:5137–5146
Pichierri P, Franchitto A, Mosesso P, Palitti F (2001) Werner’s syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol Biol Cell 12:2412–2421
Pichierri P, Rosselli F, Franchitto A (2003) Werner’s syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 22:1491–1500
Plummer ER (2006) Inhibition of poly(ADP-ribose) polymerase in cancer. Curr Opin Pharmacol 6:364–368
Poot M, Hoehn H, Rünger TM, Martin GM (1992) Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res 202:267–273
Poot M, Gollahon KA, Rabinovitch PS (1999) Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet 104:10–14
Poot M, Yom JS, Whang SH, Kato JT, Gollahon KA, Rabinovitch PS (2001) Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J 15:1224–1226
Reed E (1998) Platinum-DNA adduct, nucleotide excision repair and platinum-based anti-cancer chemotherapy. Cancer Treat Rev 24:331–344
Rodriguez-Lopez AM, Jackson DA, Iborra F, Cox LS (2002) Asymmetry of DNA replication fork progression in Werner’s syndrome. Aging Cell 1:30–39
Rodríguez-López AM, Jackson DA, Nehlin JO, Iborra F, Warren AV, Cox LS (2003) Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner’s syndrome, and an essential replication factor, PCNA. Mech Ageing Dev 124:167–174
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Plainview
Sancar A (1995) Excision repair in mammalian cells. J Biol Chem 270:15915–15918
Shen JC, Gray MD, Oshima J, Loeb LA (1998a) Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res 26:2879–2885
Shen JC, Gray MD, Oshima J, Kamath-Loeb AS, Fry M, Loeb LA (1998b) Werner syndrome protein. I. DNA helicase and DNA exonuclease reside on the same polypeptide. J Biol Chem 273:34139–34144
Shen JC, Lao Y, Kamath-Loeb A, Wold MS, Loeb LA (2003) The N-terminal domain of the large subunit of human replication protein A binds to Werner syndrome protein and stimulates helicase activity. Mech Ageing Dev 124:921–930
Sidorova JM (2008) Roles of the Werner syndrome RecQ helicase in DNA replication. DNA Repair 7:1776–1786
Sousa FG, Matuo R, Soares DG, Escargueil AE, Henriques JAP, Larsen AK, Saffi J (2012) PARPs and the DNA damage response. Carcinogenesis 33:1433–1440
States JC, Quan T, Hines RN, Novak RF, Runge-Morris M (1993) Expression of human cytochrome P450 1A1 in DNA repair deficient and proficient human fibroblasts stably transformed with an inducible expression vector. Carcinogenesis 14:1643–1649
Suzuki N, Shimamoto A, Imamura O, Kuromitsu J, Kitao S, Goto M, Furuichi Y (1997) DNA helicase activity in Werner’s syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res 25:2973–2978
Szekely AM, Chen YH, Zhang C, Oshima J, Weissman SM (2000) Werner protein recruits DNA polymerase delta to the nucleolus. Proc Natl Acad Sci USA 97:11365–11370
Takeuchi F, Hanaoka F, Goto M, Yamada M, Miyamoto T (1982) Prolongation of S phase and whole cell cycle in Werner’s syndrome fibroblasts. Exp Gerontol 17:473–480
Trimmer EE, Essigmann JM (1999) Cisplatin. Essays Biochem 34:191–211
Vaitiekunaite R, Butkiewicz D, Krzesniak M, Przybylek M, Gryc A, Snietura M, Benedyk M, Harris CC, Rusin M (2007) Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. Mech Ageing Dev 128:650–661
von Kobbe C, Thomä NH, Czyzewski BK, Pavletich NP, Bohr VA (2003) WRN syndrome protein contains three structure-specific DNA binding domains. J Biol Chem 278:52997–53006
Weston VJ, Oldreive CE, Skowronska A, Oscier DG, Pratt G, Dyer MJ, Smith G, Powell JE, Rudzki Z, Kearns P, Moss PA, Taylor AM, Stankovic T (2010) The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood 116:4578–4587
Woodhouse BC, Dianov GL (2008) PolyADP-ribose polymerase I: an international molecule of mystery. DNA Repair 7:1077–1086
Woods YL, Xirodimas DP, Prescott AR, Sparks A, Lane DP, Saville MK (2004) p14 Arf promotes small ubiquitin-like modifier conjugation of Werner’s helicase. J Biol Chem 279:50157–50166
Wyatt MD, Pittman DL (2006) Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem Res Toxicol 19:1580–1594
Yannone SM, Roy S, Chan DW, Murphy MB, Huang S, Campisi J, Chen DJ (2001) Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem 276:38242–38248
Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD (1996) Positional cloning of the Werner’s syndrome gene. Science 272:258–262
Acknowledgments
This research was supported by grants R01AG027258 and R01AG026534 to D.K.O. and J.L., respectively, from the National Institute on Aging of the National Institutes of Health. The authors would also like to thank Dr. Amrita Machwe for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lozada, E., Yi, J., Luo, J. et al. Acetylation of Werner syndrome protein (WRN): relationships with DNA damage, DNA replication and DNA metabolic activities. Biogerontology 15, 347–366 (2014). https://doi.org/10.1007/s10522-014-9506-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-014-9506-3